Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
28.63
+1.20 (4.37%)
At close: Aug 13, 2025, 4:00 PM
28.55
-0.08 (-0.28%)
After-hours: Aug 13, 2025, 4:21 PM EDT
Alkermes Employees
Alkermes had 1,800 employees as of December 31, 2024. The number of employees decreased by 300 or -14.29% compared to the previous year.
Employees
1,800
Change (1Y)
-300
Growth (1Y)
-14.29%
Revenue / Employee
$836,276
Profits / Employee
$193,581
Market Cap
4.73B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALKS News
- 14 days ago - Alkermes: A More Than Solid Quarter - Seeking Alpha
- 15 days ago - Alkermes plc (ALKS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Alkermes plc Reports Second Quarter 2025 Financial Results - PRNewsWire
- 23 days ago - Alkermes Announces Positive Topline Results From Vibrance-1 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 1 - PRNewsWire
- 4 weeks ago - Alkermes to Report Second Quarter Financial Results on July 29, 2025 - PRNewsWire
- 2 months ago - Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference - PRNewsWire
- 2 months ago - Alkermes Highlights Data From Psychiatry Portfolio at Spring 2025 Scientific Conferences - PRNewsWire
- 3 months ago - Alkermes: Label Expansion Of LYBALVI With Ongoing Pediatric Trial Possible - Seeking Alpha